Onset
Not established; no controlled trial measures a response window.
Protocol / Research Dosing Guide
Lipo-C Dosing Guide: Compounded Lipotropic Injection Context and Safety
A source-gated Lipo-C reference covering what is actually in a compounded lipotropic injection, the administration context pharmacies report, and where the evidence stops.
Last reviewed September 16, 202614 minute readResearch information only
Level 1 — No controlled trial of the combinationCompounded, not FDA approvedNot a peptide
Lipo-C Quick Start
Lipo-C is a compounded lipotropic injection: a blend a compounding pharmacy mixes, usually for weight-management programs. A common formula pairs methionine, inositol and choline, the MIC core, with L-carnitine plus vitamin B1 (thiamine) and vitamin B5 (dexpanthenol), and some clinics add B12. Despite being searched as a peptide, Lipo-C is not one; none of its ingredients form a peptide chain, which also means the storage advice written for peptides does not apply.
Why researchers care
Fat-metabolism and energy-support adjunct discussion in weight-management programs
Class
Compounded lipotropic blend of amino acids, vitamin-like nutrients and B vitamins
Route reported
Subcutaneous or intramuscular, from a ready-to-use solution
Cycle length
Used as an ongoing adjunct; no cycle established
Regulatory status
Compounded product, not FDA approved
Loading supplier information
Lipo-C Dosing Protocol and Schedule
The supplied source reports compounding-pharmacy practice of about a 1 mL injection once or twice weekly by subcutaneous or intramuscular route, with some research-market guides describing 0.5–1.0 mL two to three times weekly. Strengths and schedules vary by pharmacy.
| Phase or study | Amount | Frequency / evidence |
|---|---|---|
| Commonly reported volume | About 0.5–1 mL per injection, per the compounded label | Compounded practice |
| Commonly reported frequency | Once or twice weekly | Compounded practice |
| Alternative reported frequency | Two to three times weekly in some research-market guides | Reported practice |
| Route | Subcutaneous or intramuscular | Compounded practice |
| Cycle framing | Used as an ongoing adjunct alongside diet and exercise | Reported practice |
Lipo-C has no standardized, FDA-approved dose. Because it is compounded, strengths and schedules vary by pharmacy and prescriber, and a clinician sets any actual plan.
Lipo-C Supplies Needed
Neutral research-material planning only. This does not establish an appropriate amount or route.
Research planning item
The compounded vial, usually a ready-to-use refrigerated solution
Research planning item
U-100 syringes, 1 mL or 100-unit barrel preferred for a 1 mL draw
Research planning item
Alcohol prep swabs
Research planning item
Sharps container
Research planning item
Refrigeration as the compounded label requires
Research planning item
Bacteriostatic water only if a research-market vial ships as lyophilized powder
Lipo-C Reconstitution Calculator
Vial-format concentration math
Concentration
10 mg/mL
Draw volume
1 mL
U-100 units
100
Mathematical draws
10
Arithmetic only. The entered amount is not a recommendation and does not establish suitability.
Best Time to Take Lipo-C: Morning or Night?
Time of day?
Not established. Reported practice fixes weekly days rather than a time.
Fasted?
Not applicable; no timing requirement is established.
Route choice?
Both subcutaneous and intramuscular are reported; the compounded label governs.
Missed injection?
Follow the prescriber's instruction; no validated replacement rule exists.
Lipo-C Route Comparison
| Format | What is reported | Evidence limit |
|---|---|---|
| Subcutaneous | Commonly reported for compounded lipotropics | No controlled comparison |
| Intramuscular | Also commonly reported | No controlled comparison |
| Oral equivalents | Individual ingredients exist orally | Not equivalent to the compounded injection |
Routes and amounts are not interchangeable unless a verified study explicitly establishes a conversion.
Lipo-C Half-Life and Dosing Frequency
| Measure | Finding | Evidence limit |
|---|---|---|
| Blend half-life | Not applicable | Lipo-C is a mixture, not a single molecule |
| Component handling | Each ingredient has its own metabolism and clearance | Component specific |
| Frequency logic | Weekly schedules reflect clinic convention, not measured kinetics | Reported practice |
| Duration of effect | Not established | No controlled trial |
Lipo-C Dosage Chart
| Route | Amount | Frequency | Source | Human validation |
|---|---|---|---|---|
| Subcutaneous or intramuscular | 0.5–1 mL | Once or twice weekly | Compounded practice | No |
| Subcutaneous or intramuscular | 0.5–1 mL | Two to three times weekly | Reported practice | No |
| Example formula strength | Methionine/Inositol/Choline/L-Carnitine/B1/B5 at 15/50/50/50/15/5 mg/mL | Empower-style compounded formula | Reported | No |
Published study values describe those studies. Community-reported values are not validated dosing recommendations.
Lipo-C Reconstitution Guide
Concentration: 10 mg/mL
| Entered amount | Volume | U-100 units |
|---|---|---|
| 10 mg | 1 mL | 100 units |
| 20 mg | 2 mL | 200 units |
| 30 mg | 3 mL | 300 units |
- 1.Most compounded Lipo-C arrives as a ready-to-use refrigerated solution, so no mixing is needed.
- 2.Read the ingredient strengths printed on the vial in mg/mL; the total nutrients per injection depend on that specific formula.
- 3.Clean the stopper with an alcohol swab before each draw.
- 4.Draw the labeled volume, commonly 1 mL, using a 100-unit syringe for a readable measurement.
- 5.A 10 mL vial provides about ten 1 mL draws; a 30 mL vial provides about thirty.
- 6.If a research-market vial ships as lyophilized powder, add bacteriostatic water to a known volume first.
- 7.Record the concentration and first-use date on the vial.
- 8.Refrigerate as the compounded label requires.
Reconstitution does not establish identity, purity, sterility, stability, or an appropriate amount.
How Lipo-C Works
Lipotropic meaning
A lipotropic substance is one that helps the body move or process fat, mostly in the liver.
Lipo-C Human Trials and FDA Status
Current status · verified September 16, 2026
Compounded product, not FDA approved
- No controlled trial has tested this combination at any dose for weight loss.
- Any weight change reported by users is driven mainly by the diet and exercise plan the injection is paired with, not by the injection itself.
- Lipo-C is compounded and is not FDA approved.
- Individual components such as L-carnitine have their own separate evidence bases that do not transfer to the blend.
Who Should Avoid Lipo-C?
This is an evidence-gap and precaution list, not an approved prescribing label.
Pregnancy or breastfeeding
No safety data for the compounded blend
Known sensitivity to any component
Multi-ingredient product
Kidney or liver impairment
Component handling changes; clinician direction required
Children or adolescents
No safety data
Self-directed use
Lipo-C is a compounded prescription-context product
Lipo-C Side Effects, Risks and Safety
Injection-site reactionReported
Important limitation: Common with any injected blend.
Transient warmth or flushingReported
Important limitation: Frequently described after administration.
NauseaReported
Important limitation: No controlled incidence data.
Urine odor or color changeReported
Important limitation: Attributed to B vitamins and methionine.
Allergic reactionPossible
Important limitation: Multi-ingredient product.
Long-term effectsUnknown
Important limitation: No controlled trial of the combination.
Lipo-C Timeline and Monitoring
Reported energy effects
Anecdotal and likely attributable to B-vitamin content in deficiency states.
Weight change
Driven by the diet and activity plan, not by the injection.
Monitoring
Set by the prescribing clinician.
Lipo-C Benefits and Results: What the Evidence Shows
| Claim | Evidence level | What research shows | Important limitation |
|---|---|---|---|
| Weight loss | Not established | No controlled trial | Diet and activity drive results |
| Energy support | Not established | Anecdotal; B vitamins may matter in deficiency | No controlled trial |
| Liver fat processing | Mechanistic rationale only | Level 1 | No trial of the blend |
| Component-level evidence | Varies by ingredient | Does not transfer to the blend | Evaluate each separately |
Lipo-C Storage and Handling
Ready-to-use vial
Refrigerate as the compounded label requires.
Denaturing claims
Lipo-C is not a peptide, so storage advice written about peptide denaturation does not apply.
Light exposure
B vitamins are light-sensitive; keep the vial in its carton.
Appearance
Discard discolored or particle-containing solution.
Lipo-C Troubleshooting
Strengths differ from another clinic
Expected. Compounded formulas vary by pharmacy; follow your own label.
Stinging at the injection site
Commonly reported with lipotropic blends; raise it with the prescriber.
Bright yellow urine
Typically attributed to B-vitamin content.
Vial is powder, not liquid
That is a research-market lyophilized presentation; reconstitute to a known volume first.
No weight change
The blend has no controlled trial support for weight loss; diet and activity drive results.
Lipo-C Comparisons
| Compound | Class or mechanism | Evidence | FDA status |
|---|---|---|---|
| Lipo-C | Compounded MIC plus carnitine and B vitamins | No controlled trial of the blend | Not FDA approved |
| L-Carnitine alone | Single amino-acid-derived compound | Multiple controlled human trials | Separate evidence base |
| B12 injection | Single vitamin | Established in deficiency | Different purpose |
Lipo-C Frequently Asked Questions
Is Lipo-C a peptide?
No. Its ingredients are amino acids, vitamin-like nutrients and vitamins; none form a peptide chain.
What is in it?
Commonly methionine, inositol, choline and L-carnitine with vitamin B1 and B5; some clinics add B12.
Is it FDA approved?
No. It is a compounded product.
What is the reported volume and frequency?
About 0.5–1 mL once or twice weekly, with some plans at two to three times weekly.
Which route is used?
Subcutaneous or intramuscular, per the compounded label.
Does it cause weight loss on its own?
No controlled trial has tested the combination for weight loss.
What does 'lipotropic' mean?
A substance that helps the body move or process fat, mostly in the liver.
Does Lipo-C denature like a peptide?
No. That claim misapplies peptide storage advice to a non-peptide blend.
How many doses in a 10 mL vial?
About ten 1 mL injections.
Why is my urine bright yellow?
Typically attributed to the B-vitamin content.
What does the calculator do here?
Volume and concentration arithmetic only; it does not recommend an amount.
Sources and Research
Coverage source
1. Lipo-C protocol coverage source
Supplied coverage source for compounded administration context, ingredients and supply planning.
Open direct sourceRegulatory reference
2. FDA compounding and 503A/503B framework
Regulatory context for compounded injectable products.
Open direct sourcePublished research
3. Choline, inositol and methionine in lipid metabolism
Published background on the lipotropic components; does not evaluate the blend.
Open direct sourceMissing information flagged for review
- Controlled trial of the combination: Not established
- Standardized formula and dose: Not established
- Route comparison evidence: Not established
- Long-term safety data: Not established
- Validated cycle structure: Not established